waypoint wealth counsel bought a new position in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) in the third quarter, Holdings Channel reports. The institutional investor bought 3,421 shares of the company’s stock, valued at approximately $655,000.
Several other hedge funds have also recently modified their holdings of the stock. First Horizon Advisors Inc. boosted its holdings in Molina Healthcare by 2,140.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock worth $33,000 after buying an additional 107 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Molina Healthcare in the second quarter valued at approximately $45,000. MUFG Securities EMEA plc acquired a new stake in shares of Molina Healthcare in the second quarter worth approximately $48,000. Zions Bancorporation National Association UT boosted its stake in shares of Molina Healthcare by 121.8% in the second quarter. Zions Bancorporation National Association UT now owns 193 shares of the company’s stock worth $57,000 after acquiring an additional 106 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of Molina Healthcare by 2,744.4% during the second quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $76,000 after purchasing an additional 247 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on the company. Cantor Fitzgerald decreased their price objective on Molina Healthcare from $210.00 to $180.00 and set a “neutral” rating on the stock in a report on Friday, October 24th. Jefferies Financial Group set a $160.00 price target on shares of Molina Healthcare in a research note on Tuesday, December 16th. Morgan Stanley set a $158.00 price objective on shares of Molina Healthcare in a research note on Friday, October 24th. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a research note on Wednesday, October 8th. Finally, Barclays restated an “underweight” rating and issued a $144.00 price target (down from $185.00) on shares of Molina Healthcare in a research report on Friday, October 24th. Three equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $196.33.
Insider Transactions at Molina Healthcare
In other Molina Healthcare news, Director Richard M. Schapiro sold 357 shares of Molina Healthcare stock in a transaction on Monday, November 24th. The stock was sold at an average price of $143.02, for a total value of $51,058.14. Following the sale, the director owned 11,352 shares in the company, valued at $1,623,563.04. The trade was a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.26% of the stock is currently owned by company insiders.
Molina Healthcare Stock Performance
NYSE:MOH opened at $166.52 on Tuesday. The company’s 50-day moving average is $154.76 and its two-hundred day moving average is $184.63. Molina Healthcare, Inc has a 1-year low of $133.40 and a 1-year high of $359.97. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.68 and a quick ratio of 1.68. The firm has a market capitalization of $9.03 billion, a price-to-earnings ratio of 10.31 and a beta of 0.52.
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings results on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing the consensus estimate of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The firm had revenue of $11.48 billion for the quarter, compared to analysts’ expectations of $10.99 billion. During the same period in the previous year, the firm posted $6.01 EPS. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. Analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current year.
Molina Healthcare Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Featured Articles
- Five stocks we like better than Molina Healthcare
- Wall Street Stockpicker Names #1 Stock of 2026
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Your “birthright claim” just got activated
- Turn your “dead money” into $306+ monthly (starting this month)
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH – Free Report).
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
